NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pulmonx Corporation (NASDAQ: LUNG)

 
LUNG Technical Analysis
4
As on 9th Jun 2023 LUNG STOCK Price closed @ 12.55 and we RECOMMEND Sell for LONG-TERM with Stoploss of 20.26 & Strong Sell for SHORT-TERM with Stoploss of 27.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LUNGSTOCK Price

Open 12.20 Change Price %
High 12.60 1 Day 0.36 2.95
Low 12.06 1 Week 0.54 4.50
Close 12.55 1 Month 1.10 9.61
Volume 179480 1 Year -19.58 -60.94
52 Week High 35.65 | 52 Week Low 4.82
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
LUNG
Daily Charts
LUNG
Intraday Charts
Whats New @
Bazaartrend
LUNG
Free Analysis
 
LUNG Important Levels Intraday
RESISTANCE13.59
RESISTANCE13.26
RESISTANCE13.05
RESISTANCE12.84
SUPPORT12.26
SUPPORT12.05
SUPPORT11.84
SUPPORT11.51
 
LUNG Forecast April 2024
4th UP Forecast33.82
3rd UP Forecast27
2nd UP Forecast22.78
1st UP Forecast18.57
1st DOWN Forecast6.53
2nd DOWN Forecast2.32
3rd DOWN Forecast-1.9
4th DOWN Forecast-8.72
 
LUNG Weekly Forecast
4th UP Forecast21.93
3rd UP Forecast18.92
2nd UP Forecast17.06
1st UP Forecast15.20
1st DOWN Forecast9.90
2nd DOWN Forecast8.04
3rd DOWN Forecast6.18
4th DOWN Forecast3.17
 
LUNG Forecast2024
4th UP Forecast74.58
3rd UP Forecast54.69
2nd UP Forecast42.39
1st UP Forecast30.09
1st DOWN Forecast-4.99
2nd DOWN Forecast-17.29
3rd DOWN Forecast-29.59
4th DOWN Forecast-49.48
 
 
LUNG Other Details
Segment EQ
Market Capital 1437155072.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
LUNG Address
LUNG
 
LUNG Latest News
 
Your Comments and Response on Pulmonx Corporation
 
LUNG Business Profile
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Address: 700 Chesapeake Drive, Redwood City, CA, United States, 94063
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service